Hungarian pharmaceutical groups put their case against drug price controls

A group of pharmaceutical-related industry organizations in Hungary, including research-based and generic drugmakers, wholesalers, distributors and pharmacists, have joined forces in criticizing the government's moves on drug reimbursement and listing by the National Health Insurance Fund, the OEP.

They claim that "countless press releases and opinions have recently come to light erroneously trying to drill into us that quarterly fixation and the exclusion of expensive medicines priced above an anticipated level were in the patients' interests." These claims in this form are not true, they contend.

The facts